Cancer Prevalence and Cost of Care

SRP, in collaboration with the Healthcare Delivery Research Program (HDRP) supports research into population–based estimates and projections of the overall and site-specific cancer-attributable medical care costs in the United States. These national cancer-attributed medical care costs are substantial and projected to increase dramatically by 2030, due to population changes alone, reflecting the rising burden of cancer care among cancer survivors1.

To support this research, a Cancer Prevalence and Cost of Care website is being developed to provide detailed updated data and projections on cancer-attributable cost estimates by cancer site, phase of care, and stage at diagnosis. The new website will use the most recent linkage of the NCI’s Surveillance, Epidemiology, and End Results (SEER) -Medicare database. Estimates and projections based on the previous SEER-Medicare linkage are available in a recent publication1 and on the Cancer Trends Progress Report website. These estimates are more up-to-date than what was available in the previous cancer prevalence and costs of care website.

Publications

1. Mariotto AB, Enewold L, Zhao JX, Zeruto CA, Yabroff KR. Medical Care Costs Associated with Cancer Survivorship in the United States. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1304-12. [View Abstract]

2. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst. 2011;103(2):117-28. [View Abstract]

Last Updated: 18 Jan, 2022